Company research
Latest IS Pharma comment
IS Pharma
September 12 2008
Featured in the small cap review:
TOROTRAK
The technology with this one may be great, but without any idea what the earnings potential is there is no way to gauge what premium (if any) the shares should be on to the net cash in the balance sheet – can anyone help the Champion?
Login to download this comment
More IS Pharma research
| Type | Summary | |
|---|---|---|
| Small cap review Published: 13/06/2008 |
Poor old Chamberlin! Its foundry has been around since 1890 and now it is subject to a ‘nuisance claim’ from a new housing development. No wonder British industry has a tough time |
Subscription comments - 
Free comments